bioMONTR Labs to Provide Testing Services for CytoDyn PRO 140 Clinical Trials

Friday, October 14, 2016 Clinical Trials News J E 4

RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2016 /PRNewswire/ -- bioMONTR Labs announced today they have entered into new Master Service Agreements to provide HIV-1 viral load testing services for CytoDyn's ongoing Phase 2b PRO 140 Monotherapy Extension Study and their upcoming Phase 3 PRO 140 Monotherapy Study.

Logo -

bioMONTR Labs, a CLIA Certified lab located in Research Triangle Park, NC since 2010 offers a comprehensive menu of high-complexity, molecular assays as well other proprietary and esoteric molecular testing. Anita M. McClernon, Vice President and Director of Laboratory Services for bioMONTR Labs stated that "bioMONTR Labs is uniquely positioned to support ongoing and new clinical trials by providing access to our highly specialized, proprietary methods and expertise developed over the last 30 years. Our support provides companies with the ability to focus on developing new and better therapies for those living with HIV."

Financial terms were not disclosed. 

This content was issued through the press release distribution service at For more info visit:

To view the original version on PR Newswire, visit:




You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Nasopharyngeal Cancer Pipeline H2 2016 Market Repo...
2016 Competing in the Global Respiratory Disease T...